Identification of cardiovascular risk components in urban Chinese with metabolic syndrome and application to coronary heart disease prediction: A longitudinal study

PLoS ONE

Volumn 8, Issue 12, 2013, Pages

  Zhu, Zhenxin ^a   Liu, Yanxun ^a   Zhang, Chengqi ^b   Yuan, Zhongshang ^a   Zhang, Qian ^a   Tang, Fang ^b   Lin, Haiyan ^a   Zhang, Yongyuan ^a   Liu, Longjian ^c   Xue, Fuzhong ^a  

^a SHANDONG UNIVERSITY   (China)

^b THE FIRST AFFILIATED HOSPITAL OF SHANDONG FIRST MEDICAL UNIVERSITY   (China)

^c DREXEL UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; CARDIOVASCULAR RISK; CHINESE; COHORT ANALYSIS; CONTROLLED STUDY; DIAGNOSTIC TEST ACCURACY STUDY; DISEASE ASSOCIATION; DISEASE CLASSIFICATION; DISEASE MARKER; FACTORIAL ANALYSIS; FEMALE; HUMAN; ISCHEMIC HEART DISEASE; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; MEDICAL EXAMINATION; METABOLIC SYNDROME X; MIDDLE AGED; POPULATION BASED CASE CONTROL STUDY; PREDICTION; RECEIVER OPERATING CHARACTERISTIC; REFERENCE VALUE; RISK ASSESSMENT; SENSITIVITY AND SPECIFICITY; SEX DIFFERENCE; URBAN POPULATION; VALIDATION PROCESS;

ADULT; AGED; BIOLOGICAL MARKERS; CARDIOVASCULAR DISEASES; CHINA; CORONARY DISEASE; FEMALE; HUMANS; LONGITUDINAL STUDIES; MALE; METABOLIC SYNDROME X; MIDDLE AGED; POPULATION SURVEILLANCE; PREVALENCE; RISK; ROC CURVE; SEX FACTORS; URBAN POPULATION;

EID: 84892905557     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0084204     Document Type: Article

References (55)

1. Lakka HM, Laaksonen DE, Lakka TA, Niskanen LK, Kumpusalo E et al. (2002) The metabolic syndrome and total and cardiovascular disease mortality in middle-aged men. JAMA 288: 2709-2716. doi:10.1001/jama.288.21.2709. PubMed: 12460094.
2. Scott R, Donoghoe M, Watts GF, O'Brien R, Pardy C et al. (2011) Impact of metabolic syndrome and its components on cardiovascular disease event rates in 4900 patients with type 2 diabetes assigned to placebo in the FIELD randomised trial. Cardiovasc Diabetol 10: 102. doi:10.1186/1475-2840-10-102. PubMed: 22104275.
3. Sattar N, McConnachie A, Shaper AG, Blauw GJ, Buckley BM et al. (2008) Can metabolic syndrome usefully predict cardiovascular disease and diabetes? Outcome data from two prospective studies. Lancet 371: 1927-1935. doi:10.1016/S0140-6736(08)60602-9. PubMed: 18501419.
4. Hanson RL, Imperatore G, Bennett PH, Knowler WC (2002) Components of the "metabolic syndrome" and incidence of type 2 diabetes. Diabetes 51: 3120-3127. doi:10.2337/diabetes.51.10.3120. PubMed: 12351457.
5. Metabolic syndrome study cooperation group of Chinese diabetes society (2004) Suggestions about metabolic syndrome of Chinese diabetes society. Chin J Diab 12: 156-161
6. Grundy SM, Cleeman JI, Daniels SR, Donato KA, Eckel RH et al. (2005) Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement. Circulation 112: 2735-2752. doi:10.1161/CIRCULATIONAHA.105.169404. PubMed: 16157765.
7. Reaven GM (1993) Role of insulin resistance in human disease (syndrome X): an expanded definition. Annu Rev Med 44: 121-131. doi: 10.1146/annurev.me. 44.020193.001005. PubMed: 8476236.
8. Grundy SM, Brewer HB Jr., Cleeman JI, Smith SC Jr., Lenfant C (2004) Definition of metabolic syndrome: Report of the National Heart, Lung, and Blood Institute/American Heart Association conference on scientific issues related to definition. Circulation 109: 433-438. doi: 10.1161/01.CIR.0000111245.75752.C6. PubMed: 14744958.
9. Deedwania PC (2004) Metabolic syndrome and vascular disease: is nature or nurture leading the new epidemic of cardiovascular disease? Circulation 109: 2-4. doi:10.1161/01.CIR.0000122867.89751.59. PubMed: 14707015.
10. Steinberger J, Daniels SR, Eckel RH, Hayman L, Lustig RH et al. (2009) Progress and challenges in metabolic syndrome in children and adolescents: a scientific statement from the American Heart Association Atherosclerosis, Hypertension, and Obesity in the Young Committee of the Council on Cardiovascular Disease in the Young; Council on Cardiovascular Nursing; and Council on Nutrition, Physical Activity, and Metabolism. Circulation 119: 628-647. doi:10.1161/CIRCULATIONAHA.108.191394. PubMed: 19139390.
11. Hong TK, Trang NH, Dibley MJ (2012) Prevalence of metabolic syndrome and factor analysis of cardiovascular risk clustering among adolescents in Ho Chi Minh City. Vietnam - Prev Med 55: 409-411.
12. Tsai CH, Li TC, Lin CC, Tsay HS (2011) Factor analysis of modifiable cardiovascular risk factors and prevalence of metabolic syndrome in adult Taiwanese. Endocrine 40: 256-264. doi:10.1007/s12020-011-9466-1. PubMed: 21499818.
13. Povel CM, Beulens JW, van der Schouw YT, Dollé ME, Spijkerman AM et al. (2013) Metabolic syndrome model definitions predicting type 2 diabetes and cardiovascular disease. Diabetes Care 36: 362-368. doi: 10.2337/dc11-2546. PubMed: 22933442.
14. Stevenson JE, Wright BR, Boydstun AS (2012) The metabolic syndrome and coronary artery disease: a structural equation modeling approach suggestive of a common underlying pathophysiology. Metabolism 61: 1582-1588. doi:10.1016/j.metabol.2012.04.010. PubMed: 22626764.
15. Lempiäinen P, Mykkänen L, Pyörälä K, Laakso M, Kuusisto J (1999) Insulin resistance syndrome predicts coronary heart disease events in elderly nondiabetic men. Circulation 100: 123-128. doi:10.1161/01.CIR.100.2.123. PubMed: 10402440.
16. Pyörälä M, Miettinen H, Halonen P, Laakso M, Pyörälä K (2000) Insulin resistance syndrome predicts the risk of coronary heart disease and stroke in healthy middle-aged men: the 22-year follow-up results of the Helsinki Policemen Study. Arterioscler Thromb Vasc Biol 20: 538-544. doi:10.1161/01.ATV.20.2.538. PubMed: 10669654.
17. Lehto S, Rönnemaa T, Pyörälä K, Laakso M (2000) Cardiovascular risk factors clustering with endogenous hyperinsulinaemia predict death from coronary heart disease in patients with Type II diabetes. Diabetologia 43: 148-155. doi:10.1007/s001250050023. PubMed: 10753035.
18. Treeprasertsuk S, Leverage S, Adams LA, Lindor KD, St Sauver J et al. (2012) The Framingham risk score and heart disease in nonalcoholic fatty liver disease. Liver Int 32: 945-950. doi:10.1111/j.1478-3231.2011.02753.x. PubMed: 22299674.
19. Lemieux I, Lamarche B, Couillard C, Pascot A, Cantin B et al. (2001) Total cholesterol/HDL cholesterol ratio vs LDL cholesterol/HDL cholesterol ratio as indices of ischemic heart disease risk in men: the Quebec Cardiovascular Study. Arch Intern Med 161: 2685-2692. doi: 10.1001/archinte.161.22.2685. PubMed: 11732933.
20. Cui R, Iso H, Yamagishi K, Saito I, Kokubo Y et al. (2012) High serum total cholesterol levels is a risk factor of ischemic stroke for general Japanese population: the JPHC study. Atherosclerosis 221: 565-569. doi:10.1016/j.atherosclerosis.2012.01.013. PubMed: 22341595.
21. Suzuki K, Izumi M, Sakamoto T, Hayashi M (2011) Blood pressure and total cholesterol level are critical risks especially for hemorrhagic stroke in Akita, Japan. Cerebrovasc Dis 31: 100-106. doi:10.1159/000321506. PubMed: 21079399.
22. Cui R, Iso H, Toyoshima H, Date C, Yamamoto A et al. (2007) Serum total cholesterol levels and risk of mortality from stroke and coronary heart disease in Japanese: the JACC study. Atherosclerosis 194: 415-420. doi:10.1016/j. atherosclerosis.2006.08.022. PubMed: 16970954.
23. Kwon CH, Kim BJ, Kim BS, Kang JH (2011) Low-density lipoprotein cholesterol to apolipoprotein B ratio is independently associated with metabolic syndrome in Korean men. Metabolism 60: 1136-1141. doi: 10.1016/j.metabol.2010. 12.007. PubMed: 21306749.
24. Nebeck K, Gelaye B, Lemma S, Berhane Y, Bekele T et al. (2012) Hematological parameters and metabolic syndrome: findings from an occupational cohort in Ethiopia. Diabetes Metab Syndr 6: 22-27. doi: 10.1016/j.dsx.2012.05. 009. PubMed: 23014250.
25. Nguyen QM, Srinivasan SR, Xu JH, Chen W, Hassig S et al. (2011) Elevated liver function enzymes are related to the development of prediabetes and type 2 diabetes in younger adults: the Bogalusa Heart Study. Diabetes Care 34: 2603-2607. doi:10.2337/dc11-0919. PubMed: 21953798.
26. Xu Y, Bi YF, Xu M, Huang Y, Lu WY et al. (2011) Cross-sectional and longitudinal association of serum alanine aminotransaminase and gamma-glutamyltransferase with metabolic syndrome in middle-aged and elderly Chinese people. J Diabetes 3: 38-47. doi:10.1111/j.1753-0407.2010.00111.x. PubMed: 21199427.
27. Onat A, Can G, Ornek E, Cicek G, Ayhan E et al. (2012) Serum gamma-glutamyltransferase: independent predictor of risk of diabetes, hypertension, metabolic syndrome, and coronary disease. Obesity (Silver Spring) 20: 842-848. doi:10.1038/oby.2011.136.
28. Cheung BM, Ong KL, Tso AW, Cherny SS, Sham PC et al. (2011) Gamma-glutamyl transferase level predicts the development of hypertension in Hong Kong Chinese. Clin Chim Acta 412: 1326-1331. doi:10.1016/j.cca.2011.03.030. PubMed: 21466796.
29. Jimba S, Nakagami T, Oya J, Wasada T, Endo Y et al. (2009) Increase in gamma-glutamyltransferase level and development of established cardiovascular risk factors and diabetes in Japanese adults. Metab Syndr Relat Disord 7: 411-418. doi:10.1089/met.2008.0082. PubMed: 19419267.
30. Zhang Q, Zhang C, Song X, Lin H, Zhang D et al. (2012) A longitudinal cohort based association study between uric acid level and metabolic syndrome in Chinese Han urban male population. BMC Public Health 12: 419. doi:10.1186/1471-2458-12-419. PubMed: 22682157.
31. Sui X, Church TS, Meriwether RA, Lobelo F, Blair SN (2008) Uric acid and the development of metabolic syndrome in women and men. Metabolism 57: 845-852. doi:10.1016/j.metabol.2008.01.030. PubMed: 18502269.
32. Lin YC, Chen JD, Lo SH, Chen PC (2010) Worksite health screening programs for predicting the development of Metabolic Syndrome in middle-aged employees: a five-year follow-up study. BMC Public Health 10: 747. PubMed: 21126351.
33. Liese AD, Hense HW, Löwel H, Döring A, Tietze M et al. (1999) Association of serum uric acid with all-cause and cardiovascular disease mortality and incident myocardial infarction in the MONICA Augsburg cohort. World Health Organization Monitoring Trends and Determinants in Cardiovascular Diseases. Epidemiology 10: 391-397. doi:10.1097/00001648-199907000-00009. PubMed: 10401873.
34. Lehto S, Niskanen L, Rönnemaa T, Laakso M (1998) Serum uric acid is a strong predictor of stroke in patients with non-insulin-dependent diabetes mellitus. Stroke 29: 635-639. doi:10.1161/01.STR.29.3.635. PubMed: 9506605.
35. Meng W, Zhang C, Zhang Q, Song X, Lin H et al. (2012) Association between Leukocyte and Metabolic Syndrome in Urban Han Chinese: A Longitudinal Cohort Study. PLOS ONE 7: e49875. doi:10.1371/journal.pone.0049875. PubMed: 23209610.
36. Chen W, Srinivasan SR, Xu J, Berenson GS (2010) Black-white divergence in the relation of white blood cell count to metabolic syndrome in preadolescents, adolescents, and young adults: the Bogalusa Heart Study. Diabetes Care 33: 2474-2476. doi:10.2337/dc10-0619. PubMed: 20798336.
37. Lao XQ, Neil Thomas G, Jiang C, Zhang W, Adab P et al. (2008) White blood cell count and the metabolic syndrome in older Chinese: the Guangzhou Biobank Cohort Study. Atherosclerosis 201: 418-424. doi: 10.1016/j.atherosclerosis.2007. 12.053. PubMed: 18295770.
38. Odagiri K, Uehara A, Mizuta I, Yamamoto M, Kurata C (2011) Longitudinal study on white blood cell count and the incidence of metabolic syndrome. Intern Med 50: 2491-2498. doi:10.2169/internalmedicine.50.5877. PubMed: 22041347.
39. Lee CD, Folsom AR, Nieto FJ, Chambless LE, Shahar E et al. (2001) White blood cell count and incidence of coronary heart disease and ischemic stroke and mortality from cardiovascular disease in African-American and White men and women: atherosclerosis risk in communities study. Am J Epidemiol 154: 758-764. doi:10.1093/aje/154.8.758. PubMed: 11590089.
40. Onat A, Can G, Ademoǧlu E, Çelik E, Karagöz A et al. (2013) Coronary disease risk curve of serum creatinine is linear in Turkish men, ushaped in women. J Investig Med 61: 27-33. PubMed: 23160183.
41. Rose GA, Blackburn H (1968) Cardiovascular survey methods. Monogr Ser World Health Organ 56: 1-188. PubMed: 4972212.
42. Edwards KL, Austin MA, Newman B, Mayer E, Krauss RM et al. (1994) Multivariate analysis of the insulin resistance syndrome in women. Arterioscler Thromb 14: 1940-1945. doi:10.1161/01.ATV.14.12.1940. PubMed: 7981183.
43. Goodman E, Dolan LM, Morrison JA, Daniels SR (2005) Factor analysis of clustered cardiovascular risks in adolescence: obesity is the predominant correlate of risk among youth. Circulation 111: 1970-1977. doi:10.1161/01.CIR. 0000161957.34198.2B. PubMed: 15837951.
44. Normann J, Mueller M, Biener M, Vafaie M, Katus HA, et al. (2012) Effect of older age on diagnostic and prognostic performance of high-sensitivity troponin T in patients presenting to an emergency department. Am Heart J 164: 698-705 e694
45. Hamaguchi M, Takeda N, Kojima T, Ohbora A, Kato T et al. (2012) Identification of individuals with non-alcoholic fatty liver disease by the diagnostic criteria for the metabolic syndrome. World J Gastroenterol 18: 1508-1516. doi:10.3748/wjg.v18.i13.1508. PubMed: 22509083.
46. Treeprasertsuk S, Lopez-Jimenez F, Lindor KD (2011) Nonalcoholic fatty liver disease and the coronary artery disease. Dig Dis Sci 56: 35-45. doi:10.1007/s10620-010-1241-2. PubMed: 20464495.
47. Borges RL, Ribeiro AB, Zanella MT, Batista MC (2010) Uric Acid as a Factor in the Metabolic Syndrome. Curr Hypertens Rep 12: 113-119. doi:10.1007/s11906-010-0098-2. PubMed: 20424936.
48. Gaziano TA, Young CR, Fitzmaurice G, Atwood S, Gaziano JM (2008) Laboratory-based versus non-laboratory-based method for assessment of cardiovascular disease risk: the NHANES I Follow-up Study cohort. Lancet 371: 923-931. doi:10.1016/S0140-6736(08)60418-3. PubMed: 18342687.
49. Wilson PW, D'Agostino RB, Levy D, Belanger AM, Silbershatz H et al. (1998) Prediction of coronary heart disease using risk factor categories. Circulation 97: 1837-1847. doi:10.1161/01.CIR.97.18.1837. PubMed: 9603539.
50. Assmann G, Cullen P, Schulte H (2002) Simple scoring scheme for calculating the risk of acute coronary events based on the 10-year follow-up of the prospective cardiovascular Munster (PROCAM) study. Circulation 105: 310-315. doi:10.1161/hc0302.102575. PubMed: 11804985.
51. Conroy RM, Pyörälä K, Fitzgerald AP, Sans S, Menotti A et al. (2003) Estimation of ten-year risk of fatal cardiovascular disease in Europe: the SCORE project. Eur Heart J 24: 987-1003. doi:10.1016/S0195-668X(03) 00114-3. PubMed: 12788299.
52. Ferrario M, Chiodini P, Chambless LE, Cesana G, Vanuzzo D et al. (2005) Prediction of coronary events in a low incidence population. Assessing accuracy of the CUORE Cohort Study prediction equation. Int J Epidemiol 34: 413-421. doi:10.1093/ije/dyh405. PubMed: 15659467.
53. Liu J, Hong Y, D'Agostino RB Sr., Wu Z, Wang W et al. (2004) Predictive value for the Chinese population of the Framingham CHD risk assessment tool compared with the Chinese Multi-Provincial Cohort Study. JAMA 291: 2591-2599. doi:10.1001/jama.291.21.2591. PubMed: 15173150.
54. Wu Y, Liu X, Li X, Li Y, Zhao L et al. (2006) Estimation of 10-year risk of fatal and nonfatal ischemic cardiovascular diseases in Chinese adults. Circulation 114: 2217-2225. doi:10.1161/CIRCULATIONAHA. 105.607499. PubMed: 17088464.
55. Elkind MS, Ramakrishnan P, Moon YP, Boden-Albala B, Liu KM et al. (2010) Infectious burden and risk of stroke: the northern Manhattan study. Arch Neurol 67: 33-38. doi:10.1001/archneurol.2009.271. PubMed: 19901154.